FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2553804927> ?p ?o ?g. }

• W2553804927 endingPage "A159" @default.
• W2553804927 startingPage "A159.1" @default.
• W2553804927 abstract "Introduction Tight Junction Protein–2 (TJP-2) belongs to a family of proteins that are predominantly expressed at the junctions between epithelial cells. TJP-2 has been implicated in the progression of breast and pancreatic cancer through regulation of downstream signalling pathways responsible for invasion and metastasis. Recently, gene alterations in TJP-2 have been discovered in patients with progressive familial intrahepatic cholestasis leading us to hypothesise that TJP-2 might be differentially regulated in chronic liver disease and liver cancer. Our aim was to characterise the expression of TJP-2 in liver disease with a particular focus on malignancy. Methods The cellular localization and expression of TJP-2 in human liver tissue sections was studied using immunohistochemistry, multi-colour confocal immunofluorescence and immunocytochemistry. TJP-2 mRNA expression was quantified by qRT-PCR and protein expression was determined by western blotting of tissue lysates prepared from pathological control and diseased liver samples. Image J analysis was used to quantify expression of TJP-2 in chronic liver disease and liver cancers. Results TJP-2 expression in human tissue sections was significantly downregulated in chronic liver disease and liver cancer, specifically hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), when compared to pathological control tissue. The majority of TJP-2 protein was restricted to cellular junctions of biliary epithelial cells and hepatocytes in both pathological control and chronically diseased livers. In HCC and CCA tissue sections the protein was also found to adopt a characteristic perinuclear distribution, consistent with previous studies on pancreatic cancer cell lines. Western blotting and qRT-PCR studies revealed a significant decrease in TJP-2 expression in both chronic liver disease and primary liver cancer when compared to pathological control livers. Preliminary analysis of tissue samples taken from patients who had undergone hemihepatectomy for intrahepatic cholangiocarcinoma, and who were matched for anatomical location and tumour histology, suggested a correlation between TJP-2 expression and overall survival. Conclusion This is the first report on TJP-2 expression in liver disease. TJP-2 was expressed on epithelial cells, with reduced mRNA and protein levels detected in chronic liver disease and liver cancer, suggesting that progressive loss of this molecule may contribute to altered epithelial function in hepatic injury and malignancy. Our data suggest that measurement of TJP-2 expression might have utility in the staging of liver cancer. Disclosure of Interest None Declared" @default.
• W2553804927 created "2016-11-30" @default.
• W2553804927 creator A5013066484 @default.
• W2553804927 creator A5020402227 @default.
• W2553804927 creator A5049855693 @default.
• W2553804927 creator A5050585432 @default.
• W2553804927 creator A5070752461 @default.
• W2553804927 creator A5079297632 @default.
• W2553804927 creator A5087585718 @default.
• W2553804927 date "2016-06-01" @default.
• W2553804927 modified "2023-09-24" @default.
• W2553804927 title "PWE-041 Reduced Expression of TJP-2 Is Associated with Chronic Liver Disease and Hepatic Malignancy" @default.
• W2553804927 doi "https://doi.org/10.1136/gutjnl-2016-312388.287" @default.
• W2553804927 hasPublicationYear "2016" @default.
• W2553804927 type Work @default.
• W2553804927 sameAs 2553804927 @default.
• W2553804927 citedByCount "1" @default.
• W2553804927 countsByYear W25538049272022 @default.
• W2553804927 crossrefType "journal-article" @default.
• W2553804927 hasAuthorship W2553804927A5013066484 @default.
• W2553804927 hasAuthorship W2553804927A5020402227 @default.
• W2553804927 hasAuthorship W2553804927A5049855693 @default.
• W2553804927 hasAuthorship W2553804927A5050585432 @default.
• W2553804927 hasAuthorship W2553804927A5070752461 @default.
• W2553804927 hasAuthorship W2553804927A5079297632 @default.
• W2553804927 hasAuthorship W2553804927A5087585718 @default.
• W2553804927 hasConcept C2776231280 @default.
• W2553804927 hasConcept C2778019345 @default.
• W2553804927 hasConcept C502942594 @default.
• W2553804927 hasConcept C86803240 @default.
• W2553804927 hasConceptScore W2553804927C2776231280 @default.
• W2553804927 hasConceptScore W2553804927C2778019345 @default.
• W2553804927 hasConceptScore W2553804927C502942594 @default.
• W2553804927 hasConceptScore W2553804927C86803240 @default.
• W2553804927 hasIssue "Suppl 1" @default.
• W2553804927 hasLocation W25538049271 @default.
• W2553804927 hasOpenAccess W2553804927 @default.
• W2553804927 hasPrimaryLocation W25538049271 @default.
• W2553804927 hasRelatedWork W1908294932 @default.
• W2553804927 hasRelatedWork W1991757316 @default.
• W2553804927 hasRelatedWork W2008722499 @default.
• W2553804927 hasRelatedWork W2011595541 @default.
• W2553804927 hasRelatedWork W2053351341 @default.
• W2553804927 hasRelatedWork W2091042957 @default.
• W2553804927 hasRelatedWork W2534745925 @default.
• W2553804927 hasRelatedWork W2800542560 @default.
• W2553804927 hasRelatedWork W63349448 @default.
• W2553804927 hasRelatedWork W2525292951 @default.
• W2553804927 hasVolume "65" @default.
• W2553804927 isParatext "false" @default.
• W2553804927 isRetracted "false" @default.
• W2553804927 magId "2553804927" @default.
• W2553804927 workType "article" @default.